Literature DB >> 24855131

Microscopy outperformed in a comparison of five methods for detecting Trichomonas vaginalis in symptomatic women.

B Nathan1, J Appiah2, P Saunders2, D Heron1, T Nichols2, R Brum1, S Alexander2, P Baraitser1, C Ison2.   

Abstract

In the UK, despite its low sensitivity, wet mount microscopy is often the only method of detecting Trichomonas vaginalis infection. A study was conducted in symptomatic women to compare the performance of five methods for detecting T. vaginalis: an in-house polymerase chain reaction (PCR); Aptima T. vaginalis kit; OSOM ®Trichomonas Rapid Test; culture and microscopy. Symptomatic women underwent routine testing; microscopy and further swabs were taken for molecular testing, OSOM and culture. A true positive was defined as a sample that was positive for T. vaginalis by two or more different methods. Two hundred and forty-six women were recruited: 24 patients were positive for T. vaginalis by two or more different methods. Of these 24 patients, 21 patients were detected by real-time PCR (sensitivity 88%); 22 patients were detected by the Aptima T. vaginalis kit (sensitivity 92%); 22 patients were detected by OSOM (sensitivity 92%); nine were detected by wet mount microscopy (sensitivity 38%); and 21 were detected by culture (sensitivity 88%). Two patients were positive by just one method and were not considered true positives. All the other detection methods had a sensitivity to detect T. vaginalis that was significantly greater than wet mount microscopy, highlighting the number of cases that are routinely missed even in symptomatic women if microscopy is the only diagnostic method available.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  London; Trichomonas vaginalis; culture; diagnosis; human immunodeficiency virus; microscopy; nucleic acid amplification test; point of care test; sexually transmitted infection; symptomatic; women

Mesh:

Year:  2014        PMID: 24855131     DOI: 10.1177/0956462414534833

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  22 in total

1.  Combined Testing for Chlamydia, Gonorrhea, and Trichomonas by Use of the BD Max CT/GC/TV Assay with Genitourinary Specimen Types.

Authors:  Barbara Van Der Pol; James A Williams; DeAnna Fuller; Stephanie N Taylor; Edward W Hook
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium.

Authors:  Erica M Lokken; Jennifer E Balkus; James Kiarie; James P Hughes; Walter Jaoko; Patricia A Totten; R Scott McClelland; Lisa E Manhart
Journal:  Am J Epidemiol       Date:  2017-07-15       Impact factor: 4.897

Review 3.  [Nonviral sexually transmitted infections-epidemiology, clinical manifestations, diagnostic workup, therapy : Part 3: Treponemes, Gardnerella and trichomonads].

Authors:  P Nenoff; A Manos; I Ehrhard; C Krüger; U Paasch; P Helmbold; W Handrick
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

4.  Ureaplasma parvum and Ureaplasma urealyticum detected with the same frequency among women with and without symptoms of urogenital tract infection.

Authors:  M Marovt; D Keše; T Kotar; N Kmet; J Miljković; B Šoba; M Matičič
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-26       Impact factor: 3.267

5.  Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.

Authors:  Megan Clare Craig-Kuhn; Charleigh Granade; Christina A Muzny; Barbara Van Der Pol; Rebecca Lillis; Stephanie N Taylor; Norine Schmidt; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

6.  Integrated morphologic and molecular analysis of Trichomonas vaginalis, Mycoplasma hominis, and human papillomavirus using cytologic smear preparations.

Authors:  I Nikas; A Hapfelmeier; M Mollenhauer; D Angermeier; M Bettstetter; R Götz; M Schmidmayr; V Seifert-Klauss; A Muckenhuber; U Schenck; Gregor Weirich
Journal:  Parasitol Res       Date:  2018-03-17       Impact factor: 2.289

7.  Rapid Antigen Testing for Trichomoniasis in an Emergency Department.

Authors:  Nikki R Postenrieder; Jennifer L Reed; Elizabeth Hesse; Jessica A Kahn; Lili Ding; Charlotte A Gaydos; Anne Rompalo; Lea E Widdice
Journal:  Pediatrics       Date:  2016-06       Impact factor: 7.124

8.  Performance evaluation and acceptability of point-of-care Trichomonas vaginalis testing in adult female emergency department patients.

Authors:  Yu-Hsiang Hsieh; Mitra K Lewis; Valentina G Viertel; Deanna Myer; Richard E Rothman; Charlotte A Gaydos
Journal:  Int J STD AIDS       Date:  2020-09-30       Impact factor: 1.359

Review 9.  Clinical and Laboratory Testing for Trichomonas vaginalis Infection.

Authors:  Barbara Van Der Pol
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

10.  Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings.

Authors:  Sharon L Hillier; Michele Austin; Ingrid Macio; Leslie A Meyn; David Badway; Richard Beigi
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.